Daicel Corporation (TYO:4202)

Market Cap	357.13B
Revenue (ttm)	576.33B
Net Income (ttm)	55.67B
Shares Out	265.13M
EPS (ttm)	202.18
PE Ratio	6.66
Forward PE	6.50
Dividend	60.00 (4.31%)
Ex-Dividend Date	Mar 28, 2025

Volume	693,900
Average Volume	680,400
Open	1,359.50
Previous Close	1,362.50
Day's Range	1,344.00 - 1,359.50
52-Week Range	1,064.00 - 1,640.00
Beta	0.38
RSI	48.61
Earnings Date	May 13, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1919
• Employees: 11,134
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4202

Financial Performance

In 2023, Daicel's revenue was 558.06 billion, an increase of 3.72% compared to the previous year's 538.03 billion. Earnings were 55.83 billion, an increase of 37.24%.